| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |